{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Orange",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80701",
      "recalling_firm": "NuCare Pharmaceuticals Inc",
      "address_1": "622 W Katella Ave",
      "address_2": "N/A",
      "postal_code": "92867-4608",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed to three customers in Fl and CA",
      "recall_number": "D-1038-2018",
      "product_description": "Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
      "recall_initiation_date": "20180730",
      "center_classification_date": "20180803",
      "termination_date": "20210422",
      "report_date": "20180815",
      "code_info": "Lot # T11443; Exp. 02/28/2019"
    }
  ]
}